Barclays upgraded Newmed Energy (DKDRF) to Equal Weight from Underweight with a price target of ILS 14.20, up from ILS 11. Israeli companies navigated 2024 with “remarkable strength,” the analyst tells investors in a research note. Looking ahead, the firm sees most upside potential across banks, insurance and real estate. Inline with its relative rating approach Barclays adjusted ratings into 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.